Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Seegene, Inc.
  6. Summary
    A096530   KR7096530001

SEEGENE, INC.

(A096530)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Korea Stock Exchange
06/14/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
65800 64400 63800 63300 64200 Last
2086554 1000382 490397 467361 649985 Volume
+5.45% -2.13% -0.93% -0.78% +1.42% Change
Financials
Sales 2021 1 225 B 1,08 B 1,08 B
Net income 2021 480 B 0,42 B 0,42 B
Net cash position 2021 1 271 B 1,12 B 1,12 B
P/E ratio 2021 8,72x
Yield 2021 -
Sales 2022 884 B 0,78 B 0,78 B
Net income 2022 357 B 0,31 B 0,31 B
Net cash position 2022 1 815 B 1,60 B 1,60 B
P/E ratio 2022 10,3x
Yield 2022 0,39%
Capitalization 3 322 B 2 924 M 2 927 M
EV / Sales 2021 1,67x
EV / Sales 2022 1,70x
Nbr of Employees 744
Free-Float 67,8%
More Financials
Company
Seegene Inc is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents. The Company mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP)... 
More about the company
Ratings of Seegene, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about SEEGENE, INC.
05/25SEEGENE  : reports solid results in the first quarter of 2021 with KRW 351.8 bil..
AQ
05/23SEEGENE  : introduces an exclusive diagnostic system for diagnosing COVID-19 var..
AQ
05/18SEEGENE  : signs exclusive supply agreement with the Kuwaiti government
AQ
05/11SEEGENE  : reports solid results in the first quarter of 2021 with KRW 351.8 bil..
AQ
05/10SEEGENE  : Germany subsidiary supports the back-to-school initiative with its CO..
AQ
04/21SEEGENE  : to supply COVID-19 diagnostic tests worth 16 mil. GBP to Scotland, tr..
AQ
04/15SEEGENE  : Italy subsidiary secures public procurement for 7.15 million COVID-19..
AQ
04/12SEEGENE  : begins exporting its latest COVID-19 variant tests around the world t..
AQ
03/02SEEGENE  : Latest COVID-19 Test Can Simultaneously Target 4 Genes of SARS-CoV-2 ..
AQ
02/18SEEGENE  : posts unprecedented Q4 and 2020 FY results; writes history by joining..
AQ
02/15SEEGENE  : saliva test for COVID-19 is just as effective as NPS test
AQ
01/31SEEGENE  : develops world first COVID-19 variant test capable of identifying ori..
AQ
01/20SEEGENE  : to advance business in Latin America in the New Year
AQ
01/06SEEGENE  : COVID-19 test with saliva sample collection feature now available in ..
AQ
2020SEEGENE  : COVID-19/FluA,B/RSV test with extraction-free feature now available i..
AQ
More news
News in other languages on SEEGENE, INC.
02/12++ Analysen des Tages von Dow Jones Newswires (12.02.2021) +++
02/12SEEGENE  : ANALYSE/Südkoreas Gewinnabschöpfungsidee als internationales Vorbild?
More news
Chart SEEGENE, INC.
Duration : Period :
Seegene, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SEEGENE, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 116 750,00 KRW
Last Close Price 64 200,00 KRW
Spread / Highest target 110%
Spread / Average Target 81,9%
Spread / Lowest Target 53,4%
EPS Revisions
Managers and Directors
NameTitle
Jong-Yoon Chun Chief Executive Officer & Director
Jung-Yong Kim Director & Head-Finance
Hong-Il Yoon Independent Director
Chang-Se Lee Independent Director
Kyung-Jun Chun Director
Sector and Competitors
1st jan.Capitalization (M$)
SEEGENE, INC.-33.47%2 924
EXACT SCIENCES CORPORATION-4.51%21 705
GUARDANT HEALTH, INC.-6.73%12 155
BGI GENOMICS CO., LTD.-7.47%7 557
INVITAE CORPORATION-21.57%6 553
ADAPTIVE BIOTECHNOLOGIES CORPORATION-33.28%5 535